Brief: Reshape Lifesciences Awarded Phase I NIH SBIR Grant To Further Develop Proprietary Diabetes Bloc-Stim Neuromodulation Device
22/09/2022 14:27
Sept 22 (Reuters) - ReShape Lifesciences Inc RSLS.O :
* RESHAPE LIFESCIENCES™ AWARDED PHASE I NIH SBIR GRANT TO
FURTHER
DEVELOP PROPRIETARY DIABETES BLOC-STIM NEUROMODULATION™ DEVICE
Source text for Eikon: ID:nGNX6wwJqr
Further company coverage: RSLS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vyome Holdings
See all newsBrief: Vyome - Appoints Jerry Leonard As CFO On August 27, 2026 - SEC Filing
Biopharma firm Vyome Holdings posts Q2 net loss
Vyome Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Vyome Holdings Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Vyome Strikes Deal With Impetis Biosciences, Opening A ~$57B Market Opportunity